Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04587934 · ClinicalTrials.gov registry record · NA

Time to Accurate Heart Rate on Neonatal Outcomes

A NA study of Premature Infant and Extreme Prematurity, sponsored by Sharp HealthCare.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT04587934 is a NA study of Premature Infant and Extreme Prematurity that has completed, run by Sharp HealthCare. The registered enrollment target is 42 participants, below the 285-participant average among 9 other Premature Infant trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04587934, a NA study of Premature Infant and Extreme Prematurity, has completed, sponsored by Sharp HealthCare.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to compare the time to first heart rate displayed for iRes Warmer with ResusView and using iRes Warmer without ResusView when used in the resuscitation (e.g. Cardiopulmonary resuscitation or breathing assistance) of premature newborns (23 to 32+6 weeks gestation).

Interventions

  • DEVICE iRes Warmer with ResusView
  • OTHER iRes Warmer without ResusView

Study Locations (1)

California

  • Sharp Mary Birch Hospital for Women and Newborns - San Diego

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2021-02-01
Est. Completion 2021-12-10
Phase NA

Sponsor

Sharp HealthCare

32 total trials

What the Registry Record Tells You About NCT04587934

The ClinicalTrials.gov registry entry for NCT04587934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 9 other Premature Infant trials with a reported enrollment target (85% lower). The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Premature Infant appearing as the primary indexed condition, and to 2 interventions - of which iRes Warmer with ResusView is the first listed.

NCT04587934 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04587934 about?

NCT04587934 is a clinical study titled "Time to Accurate Heart Rate on Neonatal Outcomes". The goal of this trial is to compare the time to first heart rate displayed for iRes Warmer with ResusView and using iRes Warmer without ResusView when used in the resuscitation (e.g. Cardiopulmonary resuscitation or breathing assistance) of premature newborns (23 to 32+6 weeks gestation).

What is the current status of trial NCT04587934?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-02-01. Estimated completion is 2021-12-10.

What conditions does trial NCT04587934 study?

This clinical trial studies the following conditions: Premature Infant, Extreme Prematurity, Extremely Low Birth Weight.

What interventions are being tested in trial NCT04587934?

The interventions under investigation include: iRes Warmer with ResusView (DEVICE), iRes Warmer without ResusView (OTHER).

Who is sponsoring clinical trial NCT04587934?

This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04587934 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Infant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.